Orexa is a phase 2 pharmaceutical company that develops and commercializes therapeutics to increase food intake. Its lead compound ORE-001 is a proprietary oral formulation, based on a well known anesthetic. The company has started its first phase 2a study in the Prevention of Post-Operative Ileus.
Furthermore it is in preparation for phase 2a studies in Anorexia and Cachexia. With these three indications increased food intake could lead to an improved patient health, a shorter hospital stay and significant cost savings. Orexa was founded in 2016 and is headquartered in Herpen (Oss Region, Noord Brabant), The Netherlands.
Attractive risk/reward:
• Lower risk, because the active substance is already well known for many decades;
• Lean and fast development plan;
• Very attractive market potential.
Strong patent portfolio:
• Broad claims for all local anesthetics to increase food intake after both single and repeated administration;
• Well understood mode of action;
• Novel mode of delivery, with a proprietary oral formulation.
We are looking for partnerships with:
★ an experienced mid or big pharma company with a focus on 505(b)(2) applications for the late stage clinical development and for the marketing in the US & EU markets (and possibly more);
★ a suitable Chinese company with experience in phase 2 & phase 3 clinical trials and an effective sales channel in the majority of the Chinese market;
★ a large scale specialized animal food company or a large veterinary drug company for the veterinary applications.
We’d love to hear from you. We’ll get back to you as soon as we can!
You can contact us at info@orexa.nl.
Company Details
- Employees
- 1
- Founded
- -
- Address
- Berghemseweg 8, Herpen,nb 5373 Kh,netherlands
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.orexa.eu
- Keywords
- Pharma, Pharmaceutical product, Undernutrition, Post operative ileus, Cachexia, proprietary technology and inventions, Clinical studies, Phase IIA, 505(b)(2).
- HQ
- Herpen, NB
Orexa B.v. Questions
Orexa B.V.'s website is http://www.orexa.eu
Orexa B.V.'s LinkedIn profile is https://nl.linkedin.com/company/orexa-b-v
Orexa B.V. has
1 employees.
View email and phone details for 1
employees at Orexa B.V..
Orexa B.V.'s industry is
Pharmaceutical Manufacturing
Orexa B.V.'s top competitors are
Memory Plus,
Interfarma Corporation,
Vgw Pharma Bv,
Memoryplus.biz,
Dio Tree,
Plusvet Animal Health,
Bonborange,
Flaskworks,
Synerkine Pharma,
Orexa Therapeutics.
Orexa B.V.'s categories are Pharmaceutical Manufacturing
Orexa B.V.'s founding year is 2016
